Schwarz Roderich E, Smith David D, Keny Hemant, Iklé David N, Shibata Stephen I, Chu David Z J, Pezner Richard D
City of Hope National Medical Center, Department of General Oncologic Surgery, Duarte, California, USA.
Am J Clin Oncol. 2003 Feb;26(1):16-21. doi: 10.1097/00000421-200302000-00004.
For periampullary cancer,intraoperative radiation therapy (IORT) administered to the site with the highest locoregional recurrence risk carries the rationale to improve tumor control. An IORT effect on survival remains unclear. IORT impact on postoperative outcomes after pancreatectomy for adenocarcinoma was analyzed, with a specific attempt to correct for the nonrandom IORT treatment assignment, and to account for treatment group imbalances in the interpretation of outcome differences. A propensity-score-adjusted analysis, based on variable selection by logistic regression, was used to rebalance treatments. Between 1989 and 1999, 61 patients underwent partial or total pancreatectomy for a primary periampullary adenocarcinoma at the City of Hope National Medical Center. Diagnoses included pancreatic (n = 36), duodenal (n = 11), ampullary (n = 10), and bile duct cancer (n = 4). Thirty patients received IORT to the resection area, with a median dose of 15 Gy (range: 10-20), followed by postoperative external beam radiation (n = 24). Mortality was 0%, the complication rate 61%. Of 33 patients with a documented recurrence, 6 had an isolated locoregional recurrence only (1 IORT versus 5 no IORT, = 0.05); the systemic recurrence pattern differed as well (IORT 94%, no IORT 67%; = 0.04). IORT had no significant impact on hospital stay (overall median: 17 days), disease-free survival (16 months), and overall survival (23 months) when adjusted for those most relevant variables reflecting IORT treatment group assignment propensity. After adjustment for relevant propensity factors, IORT was not linked to a significantly increased risk for complications, hospital stay, or survival hazard. The recurrence pattern may be affected in some patients, but systemic recurrences predominate. We continue to explore IORT in combination with systemic chemotherapy.
对于壶腹周围癌,术中放疗(IORT)应用于局部区域复发风险最高的部位,其理论依据是改善肿瘤控制。IORT对生存率的影响尚不清楚。分析了IORT对胰腺癌胰十二指肠切除术后结局的影响,特别尝试纠正非随机的IORT治疗分配,并在解释结局差异时考虑治疗组的不平衡。基于逻辑回归进行变量选择的倾向评分调整分析用于重新平衡治疗。1989年至1999年期间,61例患者在希望之城国家医疗中心接受了原发性壶腹周围腺癌的部分或全胰切除术。诊断包括胰腺癌(n = 36)、十二指肠癌(n = 11)、壶腹癌(n = 10)和胆管癌(n = 4)。30例患者接受了切除区域的IORT,中位剂量为15 Gy(范围:10-20),随后接受术后外照射(n = 24)。死亡率为0%,并发症发生率为61%。在33例有记录的复发患者中,6例仅出现孤立的局部区域复发(1例IORT与5例未接受IORT,P = 0.05);全身复发模式也有所不同(IORT为94%,未接受IORT为67%;P = 0.04)。在对反映IORT治疗组分配倾向的最相关变量进行调整后,IORT对住院时间(总体中位时间:17天)、无病生存期(16个月)和总生存期(23个月)没有显著影响。在对相关倾向因素进行调整后,IORT与并发症、住院时间或生存风险的显著增加无关。复发模式可能在一些患者中受到影响,但全身复发占主导。我们继续探索IORT与全身化疗联合应用。